Answers are grounded in this paper and cite their sources.
Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities, one of the Achilles' heels of HAART. This article reviews research findings on treatment and QOL outcomes a decade into the HAART era.
No takes yet. Share an insight, caveat, or question.
Burgoyne et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: